REFRACTORY CANCER

Clinical trials for REFRACTORY CANCER explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY CANCER trials appear

Sign up with your email to follow new studies for REFRACTORY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 14 Not yet finished but already full! 3 Completed 1

New combo therapy shows promise for young cancer patients who relapsed

Disease control Completed

This early-phase study tested a combination of three treatments—pembrolizumab, decitabine, and targeted radiation—in 22 children and young adults (ages 1 to 40) with relapsed or refractory solid tumors or lymphoma. The main goals were to see if the combination is safe and tolerab…

Matched conditions: REFRACTORY CANCER

Phase: EARLY_PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control

Last updated May 12, 2026 13:40 UTC

REFRACTORY CANCER

Get alerted when new REFRACTORY CANCER trials appear

New combo therapy shows promise for young cancer patients who relapsed